Cutler Group LP
- SEC CIK
- 0001534270
- Latest filing
- Apr 19, 2024
ASND holding history
Ascendis Pharma A/S in every 13F filed by Cutler Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ASND overviewAll 13F holders of ASNDFull Q1 2024 holdings
- Shares (Q1 2024)
- 440
- Value
- $66.0K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 440 | $66.0K | <0.1% | +440 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −200−100.0% | Sold out | Holders |
| Q3 2023 | 200 | $18.0K | <0.1% | −460−69.7% | Reduced | Holders |
| Q2 2023 | 660 | $58.0K | <0.1% | +510+340.0% | Added | Holders |
| Q1 2023 | 150 | $16.0K | <0.1% | −50−25.0% | Reduced | Holders |
| Q4 2022 | 200 | $24.0K | <0.1% | +200 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,772−100.0% | Sold out | Holders |
| Q2 2022 | 1,772 | $164.0K | <0.1% | −7,883−81.6% | Reduced | Holders |
| Q1 2022 | 9,655 | $1.13M | 0.1% | +9,655 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −150−100.0% | Sold out | Holders |
| Q3 2021 | 150 | $23.0K | <0.1% | +150 | New | Holders |